Full Press Release Details
and Special Meeting of Holders of
Biotech Inc. (the "Issuer")
Instrument 51-102 - Continuous Disclosure Obligations
| General Business | Outcome of Vote | |||
| 1. | The election of the following nominees as directors of the Issuer for the ensuing year or until their successors are elected or appointed | Carried | ||
| (a) | Bradley G. Thompson | |||
| (b) | Douglas Ball | |||
| (c) | Ger Van Amersfoort | |||
| (d) | William A. Cochrane | |||
| (e) | Jim Dinning | |||
| (f) | Ed Levy | |||
| (g) | J. Mark Lievonen | |||
| (h) | Robert B. Schultz | |||
| (i) | Fred A. Stewart | |||
| 2. | The appointment of Ernst & Young LLP, Chartered Accountants, as auditors of the Issuer to hold office until the next annual meeting | Carried | ||
| Votes by Ballot | ||||
| Special Business | Outcome of Vote | Votes For | Votes Against | |
| 1. | The approval of an increase in the number of common shares reserved for issuance pursuant to the stock option plan of the Issuer | Carried | 5,138,791 | 1,894,213 |